Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (91-100 of 1,622) with videos related to

Pageof 163
Sort By:
The New England Journal of Medicine|June 20, 1985
Medical complications of "alternative" cancer therapyM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Thirty-eighth Annual Meeting of the American Society of HematologyM Markman
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Optimal management of recurrent ovarian cancerMaurie Markman
Notes and Records of the Royal Society of London|September 26, 2014
Thomas Birch's 'Weekly Letter' (1741-66): correspondence and history in the mid-eighteenth-century Royal SocietyMarkman Ellis
Oncology|December 17, 2013
Continuation or reintroduction of an antineoplastic strategy after documented disease progressionMaurie Markman
Gynecologic Oncology|December 14, 2011
Trends in treatment of advanced epithelial ovarian cancer in the Medicare populationMaurie Markman
The Western Journal of Medicine|July 1, 1985
Tuberculous peritonitis developing in a case of documented peritoneal carcinomatosisM Markman
Drugs|April 18, 2008
Pharmaceutical management of ovarian cancer : current statusMaurie Markman
Cancer|March 6, 2008
An ethical argument in support of interactions between developing world countries and pharmaceutical/biotechnology companies involved in oncology drug developmentMaurie Markman
Cancer Investigation|February 9, 2008
"Conflict-of-interest" and participation in IRB deliberations: an alternative perspectiveMaurie Markman
Pageof 163

Showing results (91-100 of 1,622) with videos related to

Sort By:
Pageof 163
The New England Journal of Medicine|June 20, 1985
Medical complications of "alternative" cancer therapyM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Thirty-eighth Annual Meeting of the American Society of HematologyM Markman
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Optimal management of recurrent ovarian cancerMaurie Markman
Notes and Records of the Royal Society of London|September 26, 2014
Thomas Birch's 'Weekly Letter' (1741-66): correspondence and history in the mid-eighteenth-century Royal SocietyMarkman Ellis
Oncology|December 17, 2013
Continuation or reintroduction of an antineoplastic strategy after documented disease progressionMaurie Markman
Gynecologic Oncology|December 14, 2011
Trends in treatment of advanced epithelial ovarian cancer in the Medicare populationMaurie Markman
The Western Journal of Medicine|July 1, 1985
Tuberculous peritonitis developing in a case of documented peritoneal carcinomatosisM Markman
Drugs|April 18, 2008
Pharmaceutical management of ovarian cancer : current statusMaurie Markman
Cancer|March 6, 2008
An ethical argument in support of interactions between developing world countries and pharmaceutical/biotechnology companies involved in oncology drug developmentMaurie Markman
Cancer Investigation|February 9, 2008
"Conflict-of-interest" and participation in IRB deliberations: an alternative perspectiveMaurie Markman
Pageof 163